Trevi Therapeutics reported cash from operations of -$17.43M and free cash flow of -$17.55M for the quarter ended Jun 2026, down 72.5% year over year. This cash flow statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||
| Net Income | -7.25M | -8.52M | -7.33M | -8.05M | -8.27M | -5.50M | -6.40M | -7.14M | -7.70M | -7.82M | -10.90M | -12.35M | -13.24M | -1.38M | -10.34M | -12.30M | -11.80M | 0.61M | -13.19M | -17.80M | ||||||||||||||
| Share-based Compensation | 3.05M | 0.54M | 4.06M | 4.14M | 4.14M | 0.50M | 5.36M | 5.38M | 5.32M | 0.53M | 7.82M | 7.96M | 7.94M | 0.92M | 9.98M | 10.24M | 9.44M | 1.35M | 12.04M | 11.78M | ||||||||||||||
| Cash from Operations | -7.24M | -6.23M | -7.09M | -6.18M | -8.58M | -6.33M | -8.20M | -9.88M | -7.28M | -6.36M | -10.47M | -8.68M | -9.56M | -9.55M | -13.48M | -10.10M | -10.88M | -7.63M | -16.69M | -17.43M | ||||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||||
| Amortizatization of Intangibles | 0.20M | 0.56M | 0.67M | 0.63M | 0.47M | 0.35M | 0.38M | 0.34M | 0.35M | 0.30M | 0.40M | 0.38M | 0.30M | 0.56M | 0.43M | 0.52M | ||||||||||||||||||
| Amortization of Deferred Charges | 0.15M | 0.16M | 0.15M | 0.14M | 0.12M | 0.10M | 0.08M | 0.10M | ||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.01M | 0.01M | 0.01M | 0.01M | 0.02M | 0.03M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.03M | 0.03M | 0.03M | ||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||||
| Change in Receivables | ||||||||||||||||||||||||||||||||||
| Change in Account Payables | -1.25M | 0.61M | -1.11M | 2.05M | -1.47M | 0.54M | -0.91M | -0.59M | -0.17M | 0.63M | 0.29M | -0.62M | 0.13M | 1.80M | -1.99M | 1.55M | -0.28M | 0.12M | -1.48M | -0.28M | ||||||||||||||
| Change in Accured Expenses | 0.09M | 0.56M | 0.01M | 0.34M | 0.31M | -1.30M | -0.06M | -0.73M | 0.82M | 0.02M | -0.94M | 2.02M | 2.20M | -0.71M | -1.50M | 0.50M | 0.14M | -0.56M | -1.07M | 0.69M | ||||||||||||||
| Other Working Capital Changes | -0.47M | -0.46M | -0.42M | 1.31M | -0.31M | 0.02M | 0.84M | 1.65M | 0.45M | -0.09M | -0.58M | -1.33M | -0.82M | 0.08M | 0.60M | 1.00M | 0.03M | -0.16M | 2.84M | 2.93M | ||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||||
| Capital Expenditures | 0.12M | 0.06M | 0.04M | 0.02M | 0.02M | 0.01M | 0.01M | 0.10M | 0.12M | |||||||||||||||||||||||||
| Change in Acquisitions & Divestments | 17.00M | 18.00M | 19.68M | 18.00M | 13.82M | 22.17M | 12.75M | 20.72M | 21.33M | 17.59M | 14.50M | 20.68M | 23.79M | 25.55M | 41.65M | |||||||||||||||||||
| Cash from Investing Activities | -4.85M | -48.31M | 8.96M | 19.64M | 17.98M | 12.85M | -8.09M | 2.77M | 7.67M | -23.87M | -9.95M | -2.61M | -50.94M | -30.61M | 16.96M | -112.04M | ||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||||
| Other financing activities | 0.05M | 13.61M | 0.00M | 51.82M | 51.18M | 2.40M | 0.06M | 0.01M | 0.00M | 0.00M | 0.00M | 0.21M | 0.16M | 0.01M | 8.22M | 2.54M | 0.22M | 1.72M | ||||||||||||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||||||||||||||
| Long-Term Debt Repayments | 0.58M | 1.75M | 1.75M | 1.75M | 1.75M | 7.66M | ||||||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 1.48M | 1.14M | 1.67M | 1.32M | 1.56M | 2.54M | 3.40M | 2.50M | 3.00M | 3.18M | ||||||||||||||||||||||||
| Net Equity Issued and Repurchased | ||||||||||||||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||||||||||
| Cash from Financing Activities | 0.13M | 13.74M | -0.62M | 55.98M | 55.30M | 0.65M | -1.70M | -7.66M | 1.51M | -0.05M | -0.03M | 5.07M | 4.98M | 51.47M | 8.71M | 110.39M | 1.63M | 0.28M | 0.22M | 164.36M | ||||||||||||||
| Change in Cash | -7.11M | 7.51M | -7.72M | -4.42M | 41.88M | -53.98M | -0.94M | 2.10M | 12.21M | 6.43M | -18.59M | -0.85M | 3.09M | 18.05M | -14.72M | 97.68M | -60.19M | -37.95M | 0.50M | 34.89M | ||||||||||||||
| Free Cash Flow | -7.24M | -6.23M | -7.09M | -6.18M | -8.58M | -6.45M | -8.25M | -9.91M | -7.30M | -6.38M | -10.47M | -8.68M | -9.56M | -9.56M | -13.48M | -10.10M | -10.89M | -7.63M | -16.79M | -17.55M | ||||||||||||||
| Net Cash Flow | -7.11M | 7.51M | -7.72M | 49.80M | 41.88M | -53.98M | -0.94M | 2.10M | 12.21M | 6.43M | -18.59M | -0.85M | 3.09M | 18.05M | -14.72M | 97.68M | -60.19M | -37.95M | 0.50M | 34.89M |